Coffee consumption and hepatocellular carcinoma in patients with HBeAg negative chronic hepatitis B

被引：1
|
作者：
Chen, Chien-Lin [1 ,2 ]
Chang, Wei-Chuan [3 ]
Hsu, Ching-Sheng [2 ,4 ,5 ]
机构：
[1] Tzu Chi Univ, Sch Med, Hualien, Taiwan
[2] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Internal Med, Div Gastroenterol, Hualien, Taiwan
[3] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Med Res, Hualien, Taiwan
[4] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Liver Dis Res Ctr, Taipei, Taiwan
[5] Tzu Chi Univ, Sch Postbaccalaureate Chinese Med, Hualien, Taiwan
来源：
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | 2020年 / 119卷 / 03期
关键词：
D O I：
10.1016/j.jfma.2019.11.020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：765 / 766
页数：2
相关论文
共 50 条
  • [41] Genotypic and phenotypic resistance to lamivudine in patients with HBeAg negative chronic hepatitis B.
    Hussain, MT
    Carmela, C
    Gramenzi, A
    Fiorino, S
    Margotti, M
    Talarico, S
    Bernardi, M
    Andreone, P
    Lok, AS
    HEPATOLOGY, 2001, 34 (04) : 325A - 325A
  • [42] RISK OF HEPATOCELLULAR CANCER AND DEATH/TRANSPLANT BETWEEN INACTIVE HEPATITIS B AND HBEAG-NEGATIVE CHRONIC HEPATITIS B WITH ANTIVIRAL AGENTS
    Choi, Gwang Hyeon
    Kim, Gi-Ae
    Choi, Jonggi
    Han, Seungbong
    Lim, Young-Suk
    GUT, 2018, 67 : A104 - A105
  • [43] When to Stop Antiviral Therapy in HBeAg-Negative Patients with Chronic Hepatitis B?
    Liaw Y.-F.
    Current Hepatology Reports, 2024, 23 (2) : 221 - 226
  • [44] Biochemical response to lamivudine treatment in HBeAg negative chronic hepatitis B patients in Iran
    Alizadeh, Amir Houshang Mohammad
    Ranjbar, Mitra
    Karimi, Babak
    Hatami, Saeed
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (26) : 4203 - 4205
  • [45] Biochemical response to lamivudine treatment in HBeAg negative chronic hepatitis B patients in Iran
    Amir Houshang Mohammad Alizadeh
    Mitra Ranjbar
    Babak Karimi
    Saeed Hatami
    World Journal of Gastroenterology, 2006, (26) : 4203 - 4205
  • [46] Role of hepatosteatosis in HBsAg seroconversion in HBeAg-negative chronic hepatitis B patients
    Bacaksiz, Ferhat
    Gokcan, Hale
    Akdogan, Meral
    Gokce, Dilara Turan
    Ari, Derya
    Gokbulut, Volkan
    Ergun, Yakup
    Ozturk, Omer
    Kacar, Sabite
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (12)
  • [47] Clinical phenotypes of hepatocellular carcinoma in patients with chronic hepatitis D compared to patients with chronic hepatitis B
    Jeschke, Matthias
    Steinhoff, Leonie
    Jochheim, Leonie
    Hild, Benedikt
    Passenberg, Moritz
    Schmidt, Hartmut
    Schramm, Christoph
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1124 - S1125
  • [48] HBV DNA change between HBeAg positive and negative patients with chronic hepatitis B
    Liu, J.
    Zhang, J.
    Lin, C. -S.
    Xu, Z.
    Gao, Z. -L.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S29 - S29
  • [49] CLINICAL PROGNOSIS OF HBEAG- NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B WITH LOW HBSAG
    Wang, Jian
    Zhu, Li
    Zhang, Zhiyi
    Yin, Shengxia
    Zhang, Shaoqiu
    Fan, Tao
    Xiong, Ye
    Jiang, Chao
    Liu, Xingxiang
    Li, Jie
    Zhu, Chuanwu
    Wu, Chao
    Huang, Rui
    HEPATOLOGY, 2024, 80 : S297 - S298
  • [50] IL28B Polymorphism Correlates with Active Hepatitis in Patients with HBeAg-Negative Chronic Hepatitis B
    Lee, I-Cheng
    Lin, Chen-Hao
    Huang, Yi-Hsiang
    Huo, Teh-Ia
    Su, Chien-Wei
    Hou, Ming-Chih
    Huang, Hui-Chun
    Lee, Kuei-Chuan
    Chan, Che-Chang
    Lin, Ming-Wei
    Lin, Han-Chieh
    Lee, Shou-Dong
    PLOS ONE, 2013, 8 (02):
12345